Home > Healthcare > Pharmaceuticals > Finished Drug Form > Anti-inflammatory Drugs Market
Anti-inflammatory Drugs Market Size
- Report ID: GMI5976
- Published Date: Jun 2023
- Report Format: PDF
Anti-inflammatory Drugs Market Size
Anti-Inflammatory Drugs Market size accounted for USD 104 billion in 2022 and is estimated to grow at 8.4% to reach USD 233.6 billion by 2032 due to increasing prevalence of inflammatory diseases coupled with growing geriatric population.
For instance, according to the World Health Organisation (WHO) report, around 14 million people had rheumatoid arthritis globally in 2021. Similarly. in 2020, according to Gastroenterology Journal, the prevalence of inflammatory bowel disease among elderly individuals appears to be rising by 5.2% annually.
| Report Attribute | Details |
|---|---|
| Base Year: | 2022 |
| Anti-Inflammatory Drugs Market Size in 2022: | USD 104 Billion |
| Forecast Period: | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR: | 8.4% |
| 2032 Value Projection: | USD 233.6 Billion |
| Historical Data for: | 2018 to 2022 |
| No. of Pages: | 180 |
| Tables, Charts & Figures: | 274 |
| Segments covered: | Drug Class, Treatment, Route of Administration, Sales Channel and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Anti-inflammatory drugs, also known as anti-inflammatories or anti-inflammatory agents, are a class of medications that help reduce inflammation in the body. Anti-inflammatory drugs work by inhibiting, reducing the production and activity of inflammatory mediators such as prostaglandins, cytokines, and leukotrienes. These drugs provide relief from symptoms and help manage inflammatory conditions such as arthritis, inflammatory bowel disease, and other chronic diseases. While these drugs can be effective, it is important to use them under the guidance of a healthcare professional due to potential side effects.
Frequently Asked Questions (FAQ) :
Anti-Inflammatory Drugs Market Scope
